A phase 2 non-randomized clinical trial tested the diagnostic potential of CAIX-PET, an experimental imaging modality, to detect VHL-related clear cell renal cell carcinoma and other VHL-associated ...
Learn diagnosis, treatments, side effects and key questions to help guide shared decisions with your oncology team after stage 4 ccRCC diagnosis. Stage 4 clear cell renal cell carcinoma (ccRCC) is the ...
ITM-94, a gallium-68-radiolabeled PET imaging agent, targets carbonic anhydrase IX, crucial in tumor growth and metastasis. The FDA's fast track designation aims to expedite ITM-94's development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results